Oncophos 1000mg Infusion
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Cyclophosphamide (1000mg)
Overview Oncophos 1000mg Infusion
Nephocin 1000mg intravenous infusion is indicated for various cancers and, following unsuccessful alternative therapies, pediatric nephrotic syndrome. Its application may extend to other conditions as prescribed by a physician. Administered intravenously by a medical professional, ideally at the same time daily, dosage and frequency are determined by your doctor based on your condition and may vary. Adhere strictly to your physician's instructions; incorrect usage or overdose can cause severe adverse reactions. Benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include emesis, nausea, alopecia, pyrexia, and hematuria; report persistent or worsening symptoms. Strategies to mitigate these effects exist. This potent medication carries a risk of serious adverse events, potentially impairing infection resistance and affecting hematologic, hepatic, or renal function; regular blood monitoring is crucial. Increased fluid intake to promote diuresis helps prevent urinary tract complications and supports renal health. Prior to treatment, disclose existing liver or kidney conditions and all medications, including anti-infectives, as drug interactions are possible. Use during pregnancy or breastfeeding is contraindicated, and effective contraception for both partners is essential.
Uses of Oncophos 1000mg Infusion
Malignancy | Nephrotic disorder
Major Benefits of Oncophos 1000mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Oncophos 1000mg Infusion:
- Vomiting
- Nausea
- Hair loss
- Fever
- Blood in urine
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Oncophos 1000mg Infusion:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
How Oncophos 1000mg Infusion works:
The intravenous formulation of Oncophos, 1000mg, combats cancer through its alkylating properties. This mechanism disrupts the DNA and RNA of malignant cells, effectively halting their proliferation and growth, thus inhibiting cancerous development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Oncophos 1000mg Infusion is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Oncophos 1000mg intravenously during pregnancy is contraindicated due to confirmed fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Oncophos 1000mg Infusion while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Oncophos 1000mg Infusion may induce adverse reactions, potentially impairing driving capabilities. These reactions can include dizziness, blurred vision, or visual disturbances, all of which may affect the ability to operate a vehicle safely.
KidneyCAUTION
Patients with severe renal impairment should receive Oncophos 1000mg Infusion with close monitoring. Dosage modification for Oncophos 1000mg Infusion may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should receive Oncophos 1000mg Infusion cautiously, with potential dose modifications as clinically indicated. Physician consultation is advised.
What if you forget to take Oncophos 1000mg Infusion :
NA
Facts to Know About Oncophos 1000mg Infusion
| Label | Value |
|---|---|
| Chemical Type | Alkylating Agents (Nitrogen Mustard Class) |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Alkylating substance |
3,018 People bought this recently